100 + INNOVATIONS
Biomedical AI Laboratory( Med-Tech. AI)
Harnessing AI for life-saving diagnostics and accelerated drug discovery
Learn More
Research Group
Challenge
Many diseases are detected late through invasive methods and the path to new medicines is incredibly slow and expensive, with high failure rates. These delays mean patients wait too long for effective diagnostics and life-saving treatments, leading to poorer health outcomes and increased healthcare costs.
Solution
The laboratory’ s AI platforms analyse vast, complex biological data to find patterns invisible to the human eye. For diagnostics, this means identifying the earliest molecular clues of disease from simple blood tests. For drug discovery, it involves rapidly predicting effective drug combinations or new uses for existing medicines. Through strong industry and clinical partnerships, these innovations are integrated into health care systems and commercial pathways to ensure sustainable, real-world impact.
Target customers / end-users
• pharmaceutical and biotechnology companies
• clinicians, hospitals and health care providers
• patients and diagnostic services.
Progress
• AU $ 16m + in competitive and industry research funding
• co-developed Australia’ s first AI-powered breast cancer blood test( partner: BCAL Diagnostics)
• built an AI platform accelerating synergistic drug discovery from years to hours( partner: Algorae Pharmaceuticals).
15 + active collaborations
Multidisciplinary team
Innovative research translation
Healthy Living
The Biomedical AI Laboratory develops sophisticated AI to transform healthcare. The group pioneers AI-enhanced, non-invasive tests for early disease detection and creates platforms that drastically shorten the timeline for drug discovery. Through deep partnerships with industry and health care providers, its research translates into realworld solutions.
• 75